An Aza-michael Addition Product Causes Incompatibility Between Etacrynic Acid and Theophylline in a Paediatric
S Jirschitzka1, U Girreser2, T Kunze3
1Department of Clinical Pharmacy, Pharmaceutical Institute, Christian-Albrechts-Universität, Kiel, Germany.
A reaction between etacrynic acid and theophylline was identified in paediatric intensive care units. This drug interaction forms an unknown compound, necessitating separate administration via distinct venous lines.
Area of Science:
- Pharmaceutical Chemistry
- Clinical Pharmacy
- Drug Compatibility Studies
Background:
- Parenteral drugs are frequently administered in paediatric cardiological intensive care units.
- Compatibility studies are essential to ensure patient safety and therapeutic efficacy.
- An unknown reaction product was observed during a compatibility assessment of etacrynic acid and theophylline.
Purpose of the Study:
- To identify the unknown reaction product formed between etacrynic acid and theophylline under intensive care unit conditions.
- To elucidate the chemical structure of the observed adduct.
- To provide recommendations for safe drug administration in clinical practice.
Main Methods:
- High-performance liquid chromatography (HPLC) was used to monitor drug concentrations and detect the reaction product.
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS) confirmed the Michael-like reaction.
- Nuclear magnetic resonance (NMR) spectroscopy (COSY, HSQC, HMBC) was employed for structural elucidation.
Main Results:
- A significant and increasing peak corresponding to a reaction product was observed in HPLC chromatograms.
- Concentrations of both etacrynic acid and theophylline decreased over time.
- The unknown compound was identified as the N-7 substituted adduct: [2-(2,3-dichloro-4-{2-[(1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)methyl]butanoyl}phenoxy)acetic acid].
Conclusions:
- Etacrynic acid and theophylline undergo a chemical reaction, forming a distinct adduct.
- This drug interaction is relevant under conditions simulating paediatric intensive care unit administration.
- It is recommended that etacrynic acid and theophylline be administered through separate venous lines to prevent this incompatibility.
More Related Videos
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
06:14Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients
Published on: October 15, 2017
Related Concept Videos
Conjugate Addition of Enolates: Michael Addition
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Determination of Michaelis Constant and Maximum Elimination Rate
These parameters can be estimated by analyzing plasma concentration data post-drug administration. A notable example of this application is phenytoin, a drug with capacity-limited kinetics. It's recommended that phenytoin should be administered at two...
Desensitization and Tachyphylaxis
Cardiopulmonary Resuscitation IV: Pharmacological Management
EDTA: Auxiliary Complexing Reagents
